Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1169P is a pseudogene of the U6 small nuclear RNA family[1][2][7]. The canonical functional form, U6 snRNA, is a non-coding RNA that functions as a core component of the spliceosome, vital for excision of introns from pre-mRNA in eukaryotic nuclei[3][5]. The U6 snRNA molecule is highly conserved, and numerous pseudogenes—genomic relics of duplicated or mutated U6 RNA sequences that do not function in splicing—are found across vertebrate genomes[1][5][7].\nRNU6-1169P lacks evidence of being a protein, enzyme, receptor, transporter, or a functional non-coding RNA. As a *pseudogene*, it neither encodes an active molecule nor is it a therapeutic target[1][2]. There is no known biological function, disease role, biomarker value, or direct drug interaction associated with RNU6-1169P[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1169, pseudogene (RNU6-1169P).